Arvinas' Vepdegestrant: Why The Data May Not Hold Up
Arvinas focuses on protein degradation, with its lead candidate, ARV-471, in Phase 3 trials for breast cancer. Read why we ...
Women in tech; IT hiring revival
The boom in global capability centres (GCCs) in India has also enabled women to take on leadership roles. About 25% of women ...